{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:10:46Z","timestamp":1714698646363},"reference-count":53,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2222\/jsv.62.87","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T22:44:40Z","timestamp":1368053080000},"page":"87-96","source":"Crossref","is-referenced-by-count":1,"title":["Human rotavirus vaccine"],"prefix":"10.2222","volume":"62","author":[{"given":"Koki","family":"TANIGUCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1)Ruiz-Palacios GM, Prez-Schael I, Velzquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lpez P, Macas-Parra M, Ortega-Barra E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pava-Ruz N, Salmern J, Rttimann R, Tinoco JC, Rubio P, Nuez E, Guerrero ML, Yarzbal JP, Damaso S, Tornieporth N, Sez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group : Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 : 11-22, 2006.","DOI":"10.1056\/NEJMoa052434"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team : Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 : 23-33, 2006.","DOI":"10.1056\/NEJMoa052664"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Doorn LJV, Muto H, Smolenov I, Suryakiran PV, Han HH: Efficacy, safety and immunogenicity of RIX4412 in Japanese infants during the first two years of life. Vaccine 29:6335-6341, 2011.","DOI":"10.1016\/j.vaccine.2011.05.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4)Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gomara M, Johne R, Kirkwood CD, Martella V, Mertens PPC, Nakagomi O, Parreno V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Ranst MVJ: Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 156:1397-1413, 2011.","DOI":"10.1007\/s00705-011-1006-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5)Kamiya H, Nakano T, Inoue M, Kamiya H, Add TT, Patel M, Orenstein WA, Parashar UD: A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirus. J Infect Dis 200:S140-146, 2009.","DOI":"10.1086\/605028"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6)Kamiya H, Nakao T, Kamiya H, Yui A, Taniguchi K, Parashar U: Rotavirus-associated acute gastroenteritis hospitalizations among Japanese children aged <5 years: active rotavirus surveillance in Mie Prefecture, Japan. Jpn J Infect Dis 64:482-487, 2011.","DOI":"10.7883\/yoken.64.482"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Parashar UD, Gibson CJ, Bresee JS, G lass RI: Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12: 304-306, 2006.","DOI":"10.3201\/eid1202.050006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Blutt SE, Kirkwood CD, Parreno V, Warfield KL, Ciarlet M, Estes MK, Bok K, Bishop RF, Conner ME : Rotavirus antigenemia and viraemia : a common event? Lancet 362 : 1445-1449, 2003.","DOI":"10.1016\/S0140-6736(03)14687-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Blutt SE, Matson DO, Crawford SE, Staat MA, Azimi P, Bennett BL, Piedra PA, Conner ME : Rotavirus antigenemia in children is associated with viremia. PLos Med 4 : e121, 2007.","DOI":"10.1371\/journal.pmed.0040121"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Chitambar SD, Tatte VS, Dhongde R, Kalrao V: High frequency of rotavirus viremia in children with acute gastroenteritis: discordance of strains detected in stool and sera. J Med Virol 80 : 2169-2176, 2008.","DOI":"10.1002\/jmv.21338"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Sugata K, Taniguchi K, Yui A, Miyake F, Suga S, Asano Y, Ohashi M, Suzuki K, Nishimura N, Ozaki T, Yoshikawa T : Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics 122 : 392-397, 2008.","DOI":"10.1542\/peds.2007-2290"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)Ramig RF: Systemic rotavirus infection. Expert Rev Anti Infect Ther 5 : 591-612, 2007.","DOI":"10.1586\/14787210.5.4.591"},{"key":"13"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14)Velzquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM : Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 : 1022-1028, 1996.","DOI":"10.1056\/NEJM199610033351404"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Ward RL, Clark HF, Offit PA:Influence of potential protective mechanisms on the development of live rotavirus vaccines. J Infect Dis 202 : S72-S79, 2010.","DOI":"10.1086\/653549"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Matthijnssens J, Joelsson DB, Warakomski DJ, Zhou T, Mathis PK, van Maanen MH, Ranheim TS, Ciarlet M: Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 403:111-127, 2010.","DOI":"10.1016\/j.virol.2010.04.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Ward RL, Bernstein DI: Rotarix: A rotavirus vaccine for the world. Clin Infect Dis 48:222-228, 2009.","DOI":"10.1086\/595702"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Gray J: Rotavirus vaccines: safety, efficacy and public health impact. J. Intern. Med. 270:206-214, 2011.","DOI":"10.1111\/j.1365-2796.2011.02409.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD: Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 30:S1-S5, 2011.","DOI":"10.1097\/INF.0b013e3181fefa1f"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20)Phua KB, Lim FS, Lau YL, Nelson EAS, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, Oostvogels LC, Suryakiran PV, Smolenov IV, Han HH, Bock HL: Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study. Vaccine 27:5936-5941, 2009.","DOI":"10.1016\/j.vaccine.2009.07.098"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21)Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P: Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis 30:S21-S24, 2011.","DOI":"10.1097\/INF.0b013e3181fefc51"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22)Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD : Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia\u2019s national childhood vaccine schedule. Pediatr Infect Dis J 30:S25-S29, 2011.","DOI":"10.1097\/INF.0b013e3181fefdee"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23)Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD: Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 29:1133-1135, 2010.","DOI":"10.1097\/INF.0b013e3181ed18ab"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24)Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, Yen C, Esposito DH, Lopman BA, Patel MM, Parashar UD: Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 30:S30-S34. 2011.","DOI":"10.1097\/INF.0b013e3181ffe3eb"},{"key":"25"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26)Taniguchi K, Hoshino Y, Nishikawa K, Green KY, Maloy WL, Morita Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M:Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J. Virol., 62:1870-1874,1988.","DOI":"10.1128\/JVI.62.6.1870-1874.1988"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Taniguchi K, Morita Y, Urasawa T, Urasawa S: Cross-reactive neutralization epitopes on VP3 of human rotavirus: Analysis with monoclonal antibodies and antigenic variants. J. Virol., 61:1726-1730, 1987.","DOI":"10.1128\/JVI.61.5.1726-1730.1987"},{"key":"28","unstructured":"28)Higo-Moriguchi, K., Akahori, Y., Iba, Y., Kurosawa, Y., Taniguchi K: Isolation of human monoclonal antibodies neutralizing human rotaviruses. J. Virol. 78:3325-3332, 2004."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29)Taniguchi K, Urasawa T , Kobayashi N, Ahmed MU, Adachi N, Chiba S, Urasawa S: Antibody Response to Serotype-Specific and Cross-Reactive Neutralization Epitopes on VP4 and VP7 After Rotavirus Infection or Vaccination. J. Clin. Microbiol., 29:483-487, 1991.","DOI":"10.1128\/JCM.29.3.483-487.1991"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30)Green KY, Taniguchi K, Mackow ER, Kapikian AZ: Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: Implications for vaccine development. J.Infect.Dis., 161:667-679,1990.","DOI":"10.1093\/infdis\/161.4.667"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31)Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-107, 1996.","DOI":"10.1126\/science.272.5258.104"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32)Dong Y, Zeng CQ, Ball JM, Estes MK, Morris AO: The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-triphosphate production. Proc Natl Acad Sci USA 94:3960-3965, 1997.","DOI":"10.1073\/pnas.94.8.3960"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33)Ward RL, Mason BB, Bernstein DI, Sander DS, Smith VE, Zandle GA, Rappaport RS: Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene. J Virol 71:6267-6270, 1997.","DOI":"10.1128\/JVI.71.8.6267-6270.1997"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34)Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ: Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 209:274-280, 1995.","DOI":"10.1006\/viro.1995.1255"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35)Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, the PAEDS\/APSU Study Group: Intussusception following rotavirus vaccine administration:post-marketing surveillance in the National Immuniztion Program in Australia. Vaccine 29:3061-3066, 2011.","DOI":"10.1016\/j.vaccine.2011.01.088"},{"key":"36","unstructured":"36)Patel MM, Lopez-Collada VR, Bulhoes MM et al: Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 362:2283-2292, 2011."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37)Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E: Risk of intussusceptions following administration of a pentavalent rotavirus vaccine in US infants. JAMA 307:598-604,2012.","DOI":"10.1001\/jama.2012.97"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38)Warfield KL, Blutt SE, Crawford SE, Kang G, Conner ME: Rotavirus infection enhances lipopolysaccharide-induced intussusceptions in a mouse model. J Virol 80:12377-a2386, 2006.","DOI":"10.1128\/JVI.01185-06"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39)Zeller M, Patton JT, Heylen E, De Coster S, Ciarlet M, Ranst MV, Matthijnssens J: Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 50:966-976, 2012.","DOI":"10.1128\/JCM.05590-11"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40)Carvalho-Costa FA, Arajo IT, Santos de Assis RM, Fialho AM, de Assis Martins CM, Bia MN, Leite JP : Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brail. Emerg Infect Dis 15 : 95-97, 2009.","DOI":"10.3201\/eid1501.071136"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41)Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA : Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 153 : 591-593, 2008.","DOI":"10.1007\/s00705-007-0028-z"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42)Zeller M, Rahman M, Heylen E, Coster SD, Vos SD, Arijs I, Novo L, Verstappen N, Van Ranst M, Matthijnssens J : Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 28 : 7507-7513, 2010.","DOI":"10.1016\/j.vaccine.2010.09.004"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43)Kirkwood CD, Boniface K, Barnes GL, Bishop RF : Distribution of rotavirus genotypes after introduction of rotavirus vaccines, rotarix and rotate, into the national immunization program of Australia. Pediatr Infect Dis J 30 : S48-S53, 2011.","DOI":"10.1097\/INF.0b013e3181fefd90"},{"key":"44"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45)Yen C, Jakob K, Esona MD, Peckham X, Rausch J, Hull JJ, Whittier S, Gentsch JR, LaRussa P: Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 29:4151-4155, 2011.","DOI":"10.1016\/j.vaccine.2011.03.074"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46)Bucardo F, Rippinger CM, Svenson L, Patton JT: Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol 12: 1282-1294, 2012.","DOI":"10.1016\/j.meegid.2012.03.007"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47)Payne D, Edwards KM, Bowen MD, Keckley E, Peters J, Esona MD, Teel EN, Kent D, Parashar UD, Gentsch JR : Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 125 : 438-441, 2010.","DOI":"10.1542\/peds.2009-1901"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48)Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, Revell PA, Hanson IC, Paul ME, Rosenblatt HM, Abramson SL: Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 362 : 314-319, 2010.","DOI":"10.1056\/NEJMoa0904485"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49)Bakare N, Menschik D, Tiernan R, Hua W, Martin D : Severe combined immunodeficiency (SCID) and rotavirus vaccination : reports to the vaccine adverse events reporting system (VAERS). Vaccine 28 : 6609-6612, 2010.","DOI":"10.1016\/j.vaccine.2010.07.039"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50)Top KA, Esquilin JM, Yen C, Esona MD, Gentsch JR, Bhatia M, LaRussa P: Detection of mutations in antigenic regions of rotavirus viral proteins 4 and 7 in a child with chronic shedding of rotavirus vaccine-type strain. Pediatr Infect Did J 30:630-632, 2011.","DOI":"10.1097\/INF.0b013e31821c38f2"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51)Armah G, Sowe S, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson K, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor J, Nyambane G, Hodgson A, Schdel F, Ciarlet M, Neuzil KM : Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomized, double-blind, placebo-controlled trial. Lancet 376 : 606-614, 2010.","DOI":"10.1016\/S0140-6736(10)60889-6"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52)Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gilard PH, Cheuvart BB, Han HH, Neuzil KM : Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362 : 289-298, 2010.","DOI":"10.1056\/NEJMoa0904797"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53)Zaman K, Dang DA, Victor JC Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schdel F, Steele AD, Neuzil KM, Ciarlet M : Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomized, double-blind, placebo-controlled trial. Lancet 376 : 615-623, 2010.","DOI":"10.1016\/S0140-6736(10)60755-6"}],"container-title":["Uirusu"],"original-title":["\u30d2\u30c8\u30ed\u30bf\u30a6\u30a4\u30eb\u30b9\u30ef\u30af\u30c1\u30f3"],"language":"en","deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T15:59:35Z","timestamp":1688227175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/62\/1\/62_87\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.62.87","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}